This, in combination with the partial depletion of preexisting CD150+ plasma and class-switched memory B cells, may result in the restriction of humoral immune responses to other pathogens after measles and thus contribute to the increased risk of opportunistic infections and other measles-associated complications. The gene discussed is SLAMF1; the disease is measles.